
Aminosaurs, Cattle, Complement, Extremophiles, Gastrointestinal System, Metals, Proline, Reproduction, Zinc
0
0
The trefoil knot fold is a protein fold in which the protein backbone is twisted into a trefoil knot shape
“Shallow” knots in which the tail of the polypeptide chain only passes through a loop by a few residues are uncommon, but “deep” knots in which many residues are passed through the loop are extremely rare. Deep trefoil knots have been found in the SPOUT superfamily. including methyltransferase proteins involved in posttranscriptional RNA modification in all three domains of life, including bacterium Thermus thermophilus and proteins, in archaea and in eukaryota.
- Zarembinski TI, Kim Y, Peterson K, Christendat D, Dharamsi A, Arrowsmith CH, Edwards AM, Joachimiak A. (2003). Deep trefoil knot implicated in RNA binding found in an archaebacterial protein. Proteins 50(2):177-83
- Nureki O, Shirouzu M, Hashimoto K, Ishitani R, Terada T, Tamakoshi M, Oshima T, Chijimatsu M, Takio K, Vassylyev DG, Shibata T, Inoue Y, Kuramitsu S, Yokoyama S. (2002). An enzyme with a deep trefoil knot for the active-site architecture. Acta Crystallogr D 58(Pt 7):1129-37
- Nureki O, Watanabe K, Fukai S, Ishii R, Endo Y, Hori H, Yokoyama S. (2004). Deep knot structure for construction of active site and cofactor binding site of tRNA modification enzyme. Structure 12(4):593-602
- Leulliot N, Bohnsack MT, Graille M, Tollervey D, Van Tilbeurgh H.(2008). The yeast ribosome synthesis factor Emg1 is a novel member of the superfamily of alpha/beta knot fold methyltransferases. Nucleic Acids Res 36(2):629-39
In many cases the trefoil knot is part of the active site or a ligand-binding site and is critical to the activity of the enzyme in which it appears. Before the discovery of the first knotted protein, it was believed that the process of protein folding could not efficiently produce deep knots in protein backbones. Studies of the folding kinetics of a dimeric protein from Haemophilus influenzae have revealed that the folding of trefoil knot proteins may depend on proline isomerization.
- Mallam AL, Jackson SE. (2006). Probing nature’s knots: the folding pathway of a knotted homodimeric protein. J Mol Biol 359(5):1420-36
Computational algorithms have been developed to identify knotted protein structures, both to canvas the Protein Data Bank for previously undetected natural knots and to identify knots in protein structure predictions, where they are unlikely to accurately reproduce the native-state structure due to the rarity of knots in known proteins.
- Khatib F, Weirauch MT, Rohl CA. (2006). Rapid knot detection and application to protein structure prediction. Bioinformatics 22(14):e252-9
Knottins are small, diverse and stable proteins with important drug design potential. They can be classified in 30 families which cover a wide range of sequences (1621 sequenced), three-dimensional structures (155 solved) and functions (> 10). Inter knottin similarity lies mainly between 20% and 40% sequence identity and 1.5 to 4 A backbone deviations although they all share a tightly knotted disulfide core. This important variability is likely to arise from the highly diverse loops which connect the successive knotted cysteines. The prediction of structural models for all knottin sequences would open new directions for the analysis of interaction sites and to provide a better understanding of the structural and functional organization of proteins sharing this scaffold.
- (Jerome Gracy and Laurent Chiche (2010). Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots. BMC Bioinformatics. 11:535)
Trefoil domain
Trefoil (P-type) domain is a cysteine-rich domain of approximately forty five amino-acid residues has been found in some extracellular eukaryotic proteins. It is known as either the ‘P’, ‘trefoil’ or ‘TFF’ domain, and contains six cysteines linked by three disulphide bonds with connectivity 1–5, 2–4, 3–6.
- Otto B, Wright N (1994). “Trefoil peptides. Coming up clover”. Curr. Biol. 4 (9): 835–838. doi:10.1016/S0960-9822(00)00186-X. PMID 7820556. S2CID 11245174.
- Thim L, Wright NA, Hoffmann W, Otto WR, Rio MC (1997). “Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer”. FEBS Lett. 408 (2): 121–123. doi:10.1016/S0014-5793(97)00424-9. PMID 9187350. S2CID 26946754.
- Bork P (1993). “A trefoil domain in the major rabbit zona pellucida protein”. Protein Sci. 2 (4): 669–670. doi:10.1002/pro.5560020417. PMC 2142363. PMID 8518738.
- Hoffmann W, Hauser F (1993). “The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia?”. Trends Biochem. Sci. 18 (7): 239–243. doi:10.1016/0968-0004(93)90170-R. PMID 8267796.
The domain has been found in a variety of extracellular eukaryotic proteins, including protein pS2 (TFF1) a protein secreted by the stomach mucosa; spasmolytic polypeptide (SP) (TFF2), a protein of about 115 residues that inhibits gastrointestinal motility and gastric acid secretion; intestinal trefoil factor (ITF) (TFF3); Xenopus laevis stomach proteins xP1 and xP4; xenopus integumentary mucins A.1 (preprospasmolysin) and C.1, proteins which may be involved in defense against microbial infections by protecting the epithelia from the external environment; xenopus skin protein xp2 (or APEG); Zona pellucida sperm-binding protein B (ZP-B); intestinal sucrase-isomaltase (EC 3.2.1.48 / EC 3.2.1.10), a vertebrate membrane bound, multifunctional enzyme complex which hydrolyzes sucrose, maltose and isomaltose; and lysosomal alpha-glucosidase (EC 3.2.1.20).
- Otto B, Wright N (1994). “Trefoil peptides. Coming up clover”. Curr. Biol. 4 (9): 835–838. doi:10.1016/S0960-9822(00)00186-X. PMID 7820556. S2CID 11245174.
- Bork P (1993). “A trefoil domain in the major rabbit zona pellucida protein”. Protein Sci. 2 (4): 669–670. doi:10.1002/pro.5560020417. PMC 2142363. PMID 8518738.
- Hoffmann W, Hauser F (1993). “The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia?”. Trends Biochem. Sci. 18 (7): 239–243. doi:10.1016/0968-0004(93)90170-R. PMID 8267796.
Examples
Human gene encoding proteins containing the trefoil domain include:
- acid alpha-glucosidase,
- Acid alpha-glucosidase, also called α-1,4-glucosidase and acid maltase, is an enzyme (EC 3.2.1.20) that helps to break down glycogen in the lysosome. It is functionally similar to glycogen debranching enzyme, but is on a different chromosome, processed differently by the cell and is located in the lysosome rather than the cytosol. In humans, it is encoded by the GAA gene. Errors in this gene cause glycogen storage disease type II (Pompe disease).
- Voet DJ, Voet JG, Pratt CW (2008). “Additional Pathways in Carbohydrate Metabolism”. Principles of Biochemistry, Third edition. Wiley. p. 538. ISBN 978-0470-23396-2.
- “Entrez Gene: GAA glucosidase, alpha; acid (Pompe disease, glycogen storage disease type II)”.
- Adeva-Andany MM, González-Lucán M, Donapetry-García C, Fernández-Fernández C, Ameneiros-Rodríguez E (June 2016). “Glycogen metabolism in humans”. BBA Clinical. 5: 85–100. doi:10.1016/j.bbacli.2016.02.001. PMC 4802397. PMID 27051594.
- Function This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. Different forms of acid alpha-glucosidase are obtained by proteolytic processing. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe disease, which is an autosomal recessive disorder with a broad clinical spectrum. Three transcript variants encoding the same protein have been found for this gene.
- Further reading
- Feizi T, Larkin M (September 1990). “AIDS and glycosylation”. Glycobiology. 1 (1): 17–23. doi:10.1093/glycob/1.1.17. PMID 2136376.
- Reuser AJ, Kroos MA, Hermans MM, Bijvoet AG, Verbeet MP, Van Diggelen OP, Kleijer WJ, Van der Ploeg AT (1995). “Glycogenosis type II (acid maltase deficiency)”. Muscle & Nerve. Supplement. 3: S61-9. doi:10.1002/mus.880181414. hdl:1765/66923. PMID 7603530. S2CID 44030591.
- Land A, Braakman I (August 2001). “Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum”. Biochimie. 83 (8): 783–90. doi:10.1016/S0300-9084(01)01314-1. hdl:1874/5091. PMID 11530211. S2CID 13576808.
- Zhong N, Martiniuk F, Tzall S, Hirschhorn R (September 1991). “Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele”. American Journal of Human Genetics. 49 (3): 635–45. PMC 1683123. PMID 1652892.
- Fenouillet E, Gluckman JC (August 1991). “Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein”. The Journal of General Virology. 72 (8): 1919–26. doi:10.1099/0022-1317-72-8-1919. PMID 1678778.
- Martiniuk F, Mehler M, Bodkin M, Tzall S, Hirschhorn K, Zhong N, Hirschhorn R (November 1991). “Identification of a missense mutation in an adult-onset patient with glycogenosis type II expressing only one allele”. DNA and Cell Biology. 10 (9): 681–7. doi:10.1089/dna.1991.10.681. PMID 1684505.
- Ratner L, vander Heyden N, Dedera D (March 1991). “Inhibition of HIV and SIV infectivity by blockade of alpha-glucosidase activity”. Virology. 181 (1): 180–92. doi:10.1016/0042-6822(91)90483-R. PMID 1704656.
- Dedera DA, Gu RL, Ratner L (March 1992). “Role of asparagine-linked glycosylation in human immunodeficiency virus type 1 transmembrane envelope function”. Virology. 187 (1): 377–82. doi:10.1016/0042-6822(92)90331-I. PMID 1736542.
- Hermans MM, Kroos MA, van Beeumen J, Oostra BA, Reuser AJ (July 1991). “Human lysosomal alpha-glucosidase. Characterization of the catalytic site”. The Journal of Biological Chemistry. 266 (21): 13507–12. doi:10.1016/S0021-9258(18)92727-4. PMID 1856189.
- Hermans MM, de Graaff E, Kroos MA, Wisselaar HA, Oostra BA, Reuser AJ (September 1991). “Identification of a point mutation in the human lysosomal alpha-glucosidase gene causing infantile glycogenosis type II”. Biochemical and Biophysical Research Communications. 179 (2): 919–26. doi:10.1016/0006-291X(91)91906-S. PMID 1898413.
- Murphy CI, Lennick M, Lehar SM, Beltz GA, Young E (October 1990). “Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding”. Genetic Analysis, Techniques and Applications. 7 (6): 160–71. doi:10.1016/0735-0651(90)90030-J. PMID 2076345.
- Martiniuk F, Mehler M, Tzall S, Meredith G, Hirschhorn R (March 1990). “Sequence of the cDNA and 5′-flanking region for human acid alpha-glucosidase, detection of an intron in the 5′ untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences”. DNA and Cell Biology. 9 (2): 85–94. doi:10.1089/dna.1990.9.85. PMID 2111708.
- Kalyanaraman VS, Rodriguez V, Veronese F, Rahman R, Lusso P, DeVico AL, Copeland T, Oroszlan S, Gallo RC, Sarngadharan MG (March 1990). “Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1”. AIDS Research and Human Retroviruses. 6 (3): 371–80. doi:10.1089/aid.1990.6.371. PMID 2187500.
- Martiniuk F, Bodkin M, Tzall S, Hirschhorn R (September 1990). “Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower “affinity” for glycogen (GAA 2) and transient gene expression in deficient cells”. American Journal of Human Genetics. 47 (3): 440–5. PMC 1683879. PMID 2203258.
- Hoefsloot LH, Hoogeveen-Westerveld M, Reuser AJ, Oostra BA (December 1990). “Characterization of the human lysosomal alpha-glucosidase gene”. The Biochemical Journal. 272 (2): 493–7. doi:10.1042/bj2720493. PMC 1149727. PMID 2268276.
- Shimizu H, Tsuchie H, Honma H, Yoshida K, Tsuruoka T, Ushijima H, Kitamura T (June 1990). “Effect of N-(3-phenyl-2-propenyl)-1-deoxynojirimycin on the lectin binding to HIV-1 glycoproteins”. Japanese Journal of Medical Science & Biology. 43 (3): 75–87. doi:10.7883/yoken1952.43.75. PMID 2283726.
- Leonard CK, Spellman MW, Riddle L, Harris RJ, Thomas JN, Gregory TJ (June 1990). “Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells”. The Journal of Biological Chemistry. 265 (18): 10373–82. doi:10.1016/S0021-9258(18)86956-3. PMID 2355006.
- Pal R, Hoke GM, Sarngadharan MG (May 1989). “Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1”. Proceedings of the National Academy of Sciences of the United States of America. 86 (9): 3384–8. Bibcode:1989PNAS…86.3384P. doi:10.1073/pnas.86.9.3384. PMC 287137. PMID 2541446.
- Dewar RL, Vasudevachari MB, Natarajan V, Salzman NP (June 1989). “Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport”. Journal of Virology. 63 (6): 2452–6. doi:10.1128/jvi.63.6.2452-2456.1989. PMC 250699. PMID 2542563.
- External links
- GeneReview/NIH/UW entry on Glycogen Storage Disease Type II (Pompe Disease)
- Human GAA genome location and GAA gene details page in the UCSC Genome Browser.
- Acid alpha-glucosidase, also called α-1,4-glucosidase and acid maltase, is an enzyme (EC 3.2.1.20) that helps to break down glycogen in the lysosome. It is functionally similar to glycogen debranching enzyme, but is on a different chromosome, processed differently by the cell and is located in the lysosome rather than the cytosol. In humans, it is encoded by the GAA gene. Errors in this gene cause glycogen storage disease type II (Pompe disease).
- MGAM,
- Maltase-glucoamylase, intestinal is an enzyme that in humans is encoded by the MGAM gene.
- “Entrez Gene: maltase-glucoamylase (alpha-glucosidase)”.
- Nichols BL, Eldering J, Avery S, Hahn D, Quaroni A, Sterchi E (January 1998). “Human small intestinal maltase-glucoamylase cDNA cloning. Homology to sucrase-isomaltase”. The Journal of Biological Chemistry. 273 (5): 3076–81. doi:10.1074/jbc.273.5.3076. PMID 9446624.
- Maltase-glucoamylase is an alpha-glucosidase digestive enzyme. It consists of two subunits with differing substrate specificity. Recombinant enzyme studies have shown that its N-terminal catalytic domain has highest activity against maltose, while the C-terminal domain has a broader substrate specificity and activity against glucose oligomers. In the small intestine, this enzyme works in synergy with sucrase-isomaltase and alpha-amylase to digest the full range of dietary starches.
- Quezada-Calvillo R, Sim L, Ao Z, Hamaker BR, Quaroni A, Brayer GD, et al. (April 2008). “Luminal starch substrate “brake” on maltase-glucoamylase activity is located within the glucoamylase subunit”. The Journal of Nutrition. 138 (4): 685–92. doi:10.1093/jn/138.4.685. PMID 18356321.
- Gene The MGAM gene –– which is located on chromosome 7q34 –– codes for the protein Maltase-Glucoamylase. An alternative name for Maltase-Glucoamylase is glucan 1,4-alpha-glycosidase.
- Nichols BL, Avery S, Sen P, Swallow DM, Hahn D, Sterchi E (February 2003). “The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities”. Proceedings of the National Academy of Sciences of the United States of America. 100 (3): 1432–7. Bibcode:2003PNAS..100.1432N. doi:10.1073/pnas.0237170100. PMC 298790. PMID 12547908.
- Ao Z, Quezada-Calvillo R, Sim L, Nichols BL, Rose DR, Sterchi EE, Hamaker BR (May 2007). “Evidence of native starch degradation with human small intestinal maltase-glucoamylase (recombinant)”. FEBS Letters. 581 (13): 2381–8. doi:10.1016/j.febslet.2007.04.035. PMID 17485087.
- Tissue distribution Maltase-glucoamylase is a membrane-bound enzyme located in the intestinal walls. This lining of the intestine forms brush border in which food has to pass in order for the intestines to absorb the food.
- Sim L, Quezada-Calvillo R, Sterchi EE, Nichols BL, Rose DR (January 2008). “Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity”. Journal of Molecular Biology. 375 (3): 782–92. doi:10.1016/j.jmb.2007.10.069. PMID 18036614.
- Enzyme mechanism This enzyme is a part of a family of enzymes called glycoside hydrolase family 31 (GH31). This is due to the digestive mechanism of the enzyme. GH31 enzymes undergo what is known as the Koshland double displacement mechanism in which a glycosylation and deglycosylation step occurs, resulting in the retention of the overall configuration of the anomeric center.
- “Glycoside hydrolases”. CAZypedia. Retrieved 2021-04-30.
- Frandsen TP, Svensson B (May 1998). “Plant alpha-glucosidases of the glycoside hydrolase family 31. Molecular properties, substrate specificity, reaction mechanism, and comparison with family members of different origin”. Plant Molecular Biology. 37 (1): 1–13. doi:10.1023/A:1005925819741. PMID 9620260. S2CID 42054886.
- Structure/N-terminal maltase The N-terminal maltase-glucoamylase enzymatic unit is in turn composed of 5 specific protein domains. The first of the 5 protein domains consist of a P-type trefoil domain containing a cysteine rich domain. Second is an N-terminal beta-sandwich domain, identified via two antiparallel beta pleated sheets. The third and largest domain consists of a catalytic (beta/alpha) barrel type domain containing two inserted loops. The fourth and 5th domains are C-terminal domains, similar to the N-terminal beta-sandwich domain. The N-terminal Maltase-glucoamylase does not have the +2/+3 sugar binding active sites and so it cannot bind to larger substrates. The N-terminal domain shows its optimal enzymatic affinity for substrates maltose, maltotriose, maltotetrose, and maltopentose.
- Structure/C-terminal glucase The C-terminal glucase enzymatic unit contains extra binding sites, which allows for it to bind to larger substrates for catalytic digestion. It was originally understood that maltase-glucoamylase’s crystalline structure was inherently similar throughout the N and C-termini. Further studies have found that the C-terminus is composed of 21 more amino acid residues than the N-terminus, which account for its difference in function. Sucrase-Isomaltase –– located on chromosome 3q26–– has a similar crystalline structure to maltase-glucoamylase and work in tandem in the human small intestine. They have been derived from a common ancestor, as they both come from the same GH31 family. As a result of having similar properties, both of these enzymes work together in the small intestine in order to convert consumed starch into glucose for metabolic energy. The difference between these two enzymes is that maltase-glucoamylase has a specific activity at the 1-4 linkage of sugar, where at SI has a specific activity at the 1-6 linkage.
- Nichols BL, Avery S, Sen P, Swallow DM, Hahn D, Sterchi E (February 2003). “The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities”. Proceedings of the National Academy of Sciences of the United States of America. 100 (3): 1432–7. Bibcode:2003PNAS..100.1432N. doi:10.1073/pnas.0237170100. PMC 298790. PMID 12547908
- Sim L, Quezada-Calvillo R, Sterchi EE, Nichols BL, Rose DR (January 2008). “Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity”. Journal of Molecular Biology. 375 (3): 782–92. doi:10.1016/j.jmb.2007.10.069. PMID 18036614.
- See also
- Alpha-glucosidase
- α-Glucosidase (EC3.2.1.20, maltase, glucoinvertase, glucosidosucrase, maltase-glucoamylase, α-glucopyranosidase, glucosidoinvertase, α-D-glucosidase, α-glucoside hydrolase, α-1,4-glucosidase, α-D-glucoside glucohydrolase; systematic name α-D-glucoside glucohydrolase) is a glucosidase located in the brush border of the small intestine that acts upon α(1→4) bonds:[alpha-Glucosidases at the U.S. National Library of Medicine Medical Subject Headings (MeSH)][Bruni, C.B.; Sica, V.; Auricchio, F.; Covelli, I. (1970). “Further kinetic and structural characterization of the lysosomal α-D-glucoside glucohydrolase from cattle liver”. Biochim. Biophys. Acta. 212 (3): 470–477. doi:10.1016/0005-2744(70)90253-6. PMID 5466143.][Flanagan, P.R.; Forstner, G.G. (1978). “Purification of rat intestinal maltase/glucoamylase and its anomalous dissociation either by heat or by low pH”. Biochem. J. 173 (2): 553–563. doi:10.1042/bj1730553. PMC 1185809. PMID 29602.][Larner, J.; Lardy, H.; Myrback, K. (1960). “Other glucosidases”. In Boyer, P.D. (ed.). The Enzymes. Vol. 4 (2nd ed.). New York: Academic Press. pp. 369–378.][Sivikami, S.; Radhakrishnan, A.N. (1973). “Purification of rabbit intestinal glucoamylase by affinity chromatography on Sephadex G-200”. Indian J. Biochem. Biophys. 10 (4): 283–284. PMID 4792946.][Sørensen, S.H.; Norén, O.; Sjöström, H.; Danielsen, E.M. (1982). “Amphiphilic pig intestinal microvillus maltase/glucoamylase. Structure and specificity”. Eur. J. Biochem. 126 (3): 559–568. doi:10.1111/j.1432-1033.1982.tb06817.x. PMID 6814909.]
- This is in contrast to EC 3.2.1.21 β-glucosidase. α-Glucosidase breaks down starch and disaccharides to glucose.
- α-Glucosidase hydrolyzes terminal non-reducing (1→4)-linked α-glucose residues to release a single α-glucose molecule.[“EC 3.2.1.20”. ExPASy. Retrieved 1 March 2012.] α-Glucosidase is a carbohydrate-hydrolase that releases α-glucose as opposed to β-glucose. β-Glucose residues can be released by glucoamylase, a functionally similar enzyme. The substrate selectivity of α-glucosidase is due to subsite affinities of the enzyme’s active site. Two proposed mechanisms include a nucleophilic displacement and an oxocarbenium ion intermediate. [Chiba S (August 1997). “Molecular mechanism in α-glucosidase and glucoamylase”. Biosci. Biotechnol. Biochem. 61 (8): 1233–9. doi:10.1271/bbb.61.1233. PMID 9301101.]
- Rhodnius prolixus, a blood-sucking insect, forms hemozoin (Hz) during digestion of host hemoglobin. Hemozoin synthesis is dependent on the substrate binding site of α-glucosidase.[Mury FB, da Silva JR, Ferreira LS, et al. (2009). “α-Glucosidase promotes hemozoin formation in a blood-sucking bug: an evolutionary history”. PLOS ONE. 4 (9): e6966. Bibcode:2009PLoSO…4.6966M. doi:10.1371/journal.pone.0006966. PMC 2734994. PMID 19742319.]
- Trout liver α-glucosidases were extracted and characterized. It was shown that for one of the trout liver α-glucosidases maximum activity of the enzyme was increased by 80% during exercise in comparison to a resting trout. This change was shown to correlate to an activity increase for liver glycogen phosphorylase. It is proposed that α-glucosidase in the glucosidic path plays an important part in complementing the phosphorolytic pathway in the liver’s metabolic response to energy demands of exercise.[ Mehrani H, Storey KB (October 1993). “Characterization of α-glucosidases from rainbow trout liver”. Arch. Biochem. Biophys. 306 (1): 188–94. doi:10.1006/abbi.1993.1499. PMID 8215402.]
- Yeast and rat small intestinal α-glucosidases have been shown to be inhibited by several groups of flavonoids.[Tadera K, Minami Y, Takamatsu K, Matsuoka T (April 2006). “Inhibition of α-glucosidase and α-amylase by flavonoids”. J. Nutr. Sci. Vitaminol. 52 (2): 149–53. doi:10.3177/jnsv.52.149. PMID 16802696.]
- α-Glucosidases can be divided, according to primary structure, into two families.[Chiba S (August 1997). “Molecular mechanism in α-glucosidase and glucoamylase”. Biosci. Biotechnol. Biochem. 61 (8): 1233–9. doi:10.1271/bbb.61.1233. PMID 9301101.] The gene coding for human lysosomal α-glucosidase is about 20 kb long and its structure has been cloned and confirmed.[Hoefsloot L; M Hoogeveen-Westerveld; A J Reuser; B A Oostra (1 December 1990). “Characterization of the human lysosomal α-glucosidase gene”. Biochem. J. 272 (2): 493–497. doi:10.1042/bj2720493. PMC 1149727. PMID 2268276.]
- Human lysosomal α-glucosidase has been studied for the significance of the Asp-518 and other residues in proximity of the enzyme’s active site. It was found that substituting Asp-513 with Glu-513 interferes with posttranslational modification and intracellular transport of α-glucosidase’s precursor. Additionally, the Trp-516 and Asp-518 residues have been deemed critical for the enzyme’s catalytic functionality.[Hermans, Monique; Marian Kroos; Jos Van Beeumen; Ben Oostra; Arnold Reuser (25 July 1991). “Human Lysosomal a-Glucosidase Characterization of The Catalytic Site”. The Journal of Biological Chemistry. 21. 266 (21): 13507–13512. doi:10.1016/S0021-9258(18)92727-4. Retrieved 1 March 2012.]
- Kinetic changes in α-glucosidase have been shown to be induced by denaturants such as guanidinium chloride (GdmCl) and SDS solutions. These denaturants cause loss of activity and conformational change. A loss of enzyme activity occurs at much lower concentrations of denaturant than required for conformational changes. This leads to a conclusion that the enzyme’s active site conformation is less stable than the whole enzyme conformation in response to the two denaturants.[Wu XQ, Xu H, Yue H, Liu KQ, Wang XY (December 2009). “Inhibition kinetics and the aggregation of α-glucosidase by different denaturants”. Protein J. 28 (9–10): 448–56. doi:10.1007/s10930-009-9213-0. PMID 19921411. S2CID 36546023.]
- Disease relevance
- Glycogen storage disease type II, also called Pompe disease: a disorder in which α-glucosidase is deficient. In 2006, the drug alglucosidase alfa became the first released treatment for Pompe disease and acts as an analog to α-glucosidase.[“FDA Approves First Treatment for Pompe Disease”. FDA News Release. FDA. Retrieved 1 March 2012.] Further studies of alglucosidase alfa revealed that iminosugars exhibit inhibition of the enzyme. It was found that one compound molecule binds to a single enzyme molecule. It was shown that 1-deoxynojirimycin (DNJ) would bind the strongest of the sugars tested and blocked the active site of the enzyme almost entirely. The studies enhanced knowledge of the mechanism by which α-glucosidase binds to imino sugars.[Yoshimizu, M.; Tajima, Y; Matsuzawa, F; Aikawa, S; Iwamoto, K; Kobayashi, T; Edmunds, T; Fujishima, K; Tsuji, D; Itoh, K; Ikekita, M; Kawashima, I; Sugawara, K; Ohyanagi, N; Suzuki, T; Togawa, T; Ohno, K; Sakuraba, H (May 2008). “Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid α-glucosidase (alglucosidase alfa): insight into the complex formation mechanism”. Clin Chim Acta. 391 (1–2): 68–73. doi:10.1016/j.cca.2008.02.014. PMID 18328816.]
- Diabetes: Acarbose, an α-glucosidase inhibitor, competitively and reversibly inhibits α-glucosidase in the intestines. This inhibition lowers the rate of glucose absorption through delayed carbohydrate digestion and extended digestion time. Acarbose may be able to prevent the development of diabetic symptoms.[Bischoff H (August 1995). “The mechanism of α-glucosidase inhibition in the management of diabetes”. Clin Invest Med. 18 (4): 303–11. PMID 8549017.] Hence, α-glucosidase inhibitors (like acarbose) are used as anti-diabetic drugs in combination with other anti-diabetic drugs. Luteolin has been found to be a strong inhibitor of α-glucosidase. The compound can inhibit the enzyme up to 36% with a concentration of 0.5 mg/ml.[Kim JS, Kwon CS, Son KH (November 2000). “Inhibition of α-glucosidase and amylase by luteolin, a flavonoid”. Biosci. Biotechnol. Biochem. 64 (11): 2458–61. doi:10.1271/bbb.64.2458. PMID 11193416. S2CID 5757649] As of 2016, this substance is being tested in rats, mice and cell culture. Flavonoid analogues have been demonstrated with inhibition activity.[Zhen, et al. (November 2017). “Synthesis of novel flavonoid alkaloids as α-glucosidase inhibitors”. Bioorganic & Medicinal Chemistry. 25 (20): 5355–64. doi:10.1016/j.bmc.2017.07.055. PMID 28797772.]
- Azoospermia: Diagnosis of azoospermia has potential to be aided by measurement of α-glucosidase activity in seminal plasma. Activity in the seminal plasma corresponds to the functionality of the epididymis.[Mahmoud AM, Geslevich J, Kint J, et al. (March 1998). “Seminal plasma α-glucosidase activity and male infertility”. Hum. Reprod. 13 (3): 591–5. doi:10.1093/humrep/13.3.591. PMID 9572418.]
- Antiviral agents: Many animal viruses possess an outer envelope composed of viral glycoproteins. These are often required for the viral life cycle and utilize cellular machinery for synthesis. Inhibitors of α-glucosidase show that the enzyme is involved in the pathway for N-glycans for viruses such as HIV and human hepatitis B virus (HBV). Inhibition of α-glucosidase can prevent fusion of HIV and secretion of HBV.[Mehta, Anand; Zitzmann, Nicole; Rudd, Pauline M; Block, Timothy M; Dwek, Raymond A (23 June 1998). “α-Glucosidase inhibitors as potential broad based anti-viral agents”. FEBS Letters. 430 (1–2): 17–22. doi:10.1016/S0014-5793(98)00525-0. PMID 9678587. S2CID 25156942.]
- Maltase
- alpha-glucosidase, glucoinvertase, glucosidosucrase, maltase-glucoamylase, alpha-glucopyranosidase, glucosidoinvertase, alpha-D-glucosidase, alpha-glucoside hydrolase, alpha-1,4-glucosidase, alpha-D-glucoside glucohydrolase) is one type of alpha-glucosidase enzymes located in the brush border of the small intestine.[“Maltase: Baking Ingredients”. BAKERpedia. 14 January 2021.][Quezada-Calvillo R, Robayo-Torres CC, Opekun AR, Sen P, Ao Z, Hamaker BR, et al. (July 2007). “Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch alpha-glucogenesis”. The Journal of Nutrition. 137 (7): 1725–33. doi:10.1093/jn/137.7.1725. PMID 17585022.] This enzyme catalyzes the hydrolysis of disaccharide maltose into two simple sugars of glucose. Maltase is found in plants, bacteria, yeast, humans, and other vertebrates. It is thought to be synthesized by cells of the mucous membrane lining the intestinal wall.[The Editors (8 June 2020). “Maltase”. Encyclopedia Britannica.
{{cite encyclopedia}}
:|author=
has generic name (help)] - Digestion of starch requires six intestinal enzymes. Two of these enzymes are luminal endo-glucosidases named alpha-amylases. The other four enzymes have been identified as different maltases, exo-glucosidases bound to the luminal surface of enterocytes. Two of these maltase activities were associated with sucrase-isomaltase (maltase Ib, maltase Ia). The other two maltases with no distinguishing characteristics were named maltase-glucoamylase (maltases II and III). The activities of these four maltases are also described as alpha-glucosidase because they all digest linear starch oligosaccharides to glucose.[Nichols BL, Baker SS, Quezada-Calvillo R (June 2018). “Metabolic Impacts of Maltase Deficiencies”. Journal of Pediatric Gastroenterology and Nutrition. 66 Suppl 3 (3): S24–S29. doi:10.1097/MPG.0000000000001955. PMID 29762372. S2CID 46891498.][Quezada-Calvillo R, Robayo-Torres CC, Opekun AR, Sen P, Ao Z, Hamaker BR, et al. (July 2007). “Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch alpha-glucogenesis”. The Journal of Nutrition. 137 (7): 1725–33. doi:10.1093/jn/137.7.1725. PMID 17585022.]
- In most cases, it is equivalent to alpha-glucosidase, but the term “maltase” emphasizes the disaccharide nature of the substrate from which glucose is cleaved, and “alpha-glucosidase” emphasizes the bond, whether the substrate is a disaccharide or polysaccharide.[citation needed]
- Vampire bats are the only vertebrates known to not exhibit intestinal maltase activity. [Schondube JE, Herrera-M LG, Martínez del Rio C (2001). “Diet and the evolution of digestion and renal function in phyllostomid bats” (PDF). Zoology. 104 (1): 59–73. doi:10.1078/0944-2006-00007. PMID 16351819.]
- alpha-glucosidase, glucoinvertase, glucosidosucrase, maltase-glucoamylase, alpha-glucopyranosidase, glucosidoinvertase, alpha-D-glucosidase, alpha-glucoside hydrolase, alpha-1,4-glucosidase, alpha-D-glucoside glucohydrolase) is one type of alpha-glucosidase enzymes located in the brush border of the small intestine.[“Maltase: Baking Ingredients”. BAKERpedia. 14 January 2021.][Quezada-Calvillo R, Robayo-Torres CC, Opekun AR, Sen P, Ao Z, Hamaker BR, et al. (July 2007). “Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch alpha-glucogenesis”. The Journal of Nutrition. 137 (7): 1725–33. doi:10.1093/jn/137.7.1725. PMID 17585022.] This enzyme catalyzes the hydrolysis of disaccharide maltose into two simple sugars of glucose. Maltase is found in plants, bacteria, yeast, humans, and other vertebrates. It is thought to be synthesized by cells of the mucous membrane lining the intestinal wall.[The Editors (8 June 2020). “Maltase”. Encyclopedia Britannica.
- Alpha-glucosidase
- Further reading
- Nichols BL, Avery S, Sen P, Swallow DM, Hahn D, Sterchi E (February 2003). “The maltase-glucoamylase gene: common ancestry to sucrase-isomaltase with complementary starch digestion activities”. Proceedings of the National Academy of Sciences of the United States of America. 100 (3): 1432–7. Bibcode:2003PNAS..100.1432N. doi:10.1073/pnas.0237170100. PMC 298790. PMID 12547908.
- Takeshita F, Ishii KJ, Kobiyama K, Kojima Y, Coban C, Sasaki S, et al. (August 2005). “TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF”. European Journal of Immunology. 35 (8): 2477–85. doi:10.1002/eji.200526151. PMID 16052631.
- Danielsen EM (October 1987). “Tyrosine sulfation, a post-translational modification of microvillar enzymes in the small intestinal enterocyte”. The EMBO Journal. 6 (10): 2891–6. doi:10.1002/j.1460-2075.1987.tb02592.x. PMC 553723. PMID 3121301.
- Korpela MP, Paetau A, Löfberg MI, Timonen MH, Lamminen AE, Kiuru-Enari SM (July 2009). “A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy”. Muscle & Nerve. 40 (1): 143–8. doi:10.1002/mus.21291. PMID 19472353. S2CID 20120101.
- Sim L, Quezada-Calvillo R, Sterchi EE, Nichols BL, Rose DR (January 2008). “Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity”. Journal of Molecular Biology. 375 (3): 782–92. doi:10.1016/j.jmb.2007.10.069. PMID 18036614.
- Naim HY, Sterchi EE, Lentze MJ (December 1988). “Structure, biosynthesis, and glycosylation of human small intestinal maltase-glucoamylase”. The Journal of Biological Chemistry. 263 (36): 19709–17. doi:10.1016/S0021-9258(19)77693-5. PMID 3143729.
- Ao Z, Quezada-Calvillo R, Sim L, Nichols BL, Rose DR, Sterchi EE, Hamaker BR (May 2007). “Evidence of native starch degradation with human small intestinal maltase-glucoamylase (recombinant)”. FEBS Letters. 581 (13): 2381–8. doi:10.1016/j.febslet.2007.04.035. PMID 17485087. S2CID 23891882.
- Tuğrul S, Kutlu T, Pekin O, Bağlam E, Kiyak H, Oral O (October 2008). “Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome”. Fertility and Sterility. 90 (4): 1144–8. doi:10.1016/j.fertnstert.2007.07.1326. PMID 18377903.
- External links
- PDBe-KB provides an overview of all the structure information available in the PDB for Human Maltase-glucoamylase, intestinal
- Maltase-glucoamylase, intestinal is an enzyme that in humans is encoded by the MGAM gene.
- TFF1,
- Trefoil factor 1 is a protein that in humans is encoded by the TFF1 gene (also called pS2 gene).
- Gött P, Beck S, Machado JC, Carneiro F, Schmitt H, Blin N (May 1997). “Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression”. Eur J Hum Genet. 4 (6): 308–15. doi:10.1159/000472224. PMID 9043862. S2CID 25235589.
- “Entrez Gene: TFF1 trefoil factor 1”.
- Chatagnon A, Ballestar E, Esteller M, Dante R (2010). “A Role for Methyl-CpG Binding Domain Protein 2 in the Modulation of the Estrogen Response of pS2/TFF1 Gene”. PLOS ONE. 5 (3): e9665. Bibcode:2010PLoSO…5.9665C. doi:10.1371/journal.pone.0009665. PMC 2837351. PMID 20300195.
- Function Members of the trefoil family are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides. They are stable secretory proteins expressed in gastrointestinal mucosa. Their functions are not defined, but they may protect the mucosa from insults, stabilize the mucus layer, and affect healing of the epithelium. This gene, which is expressed in the gastric mucosa, has also been studied because of its expression in human tumors. This gene and two other related trefoil family member genes are found in a cluster on chromosome 21.
- Glycan binding All three human trefoil factors are lectins that interact specifically with the disaccharide GlcNAc-α-1,4-Gal. This disaccharide is an unusual glycotope that is only known to exist on the large, heavily glycosylated, mucins in the mucosa. By cross-linking mucins through the bivalent binding of this glycotope, the trefoil factors are then able to reversibly modulate the thickness and viscosity of the mucus.
- Järvå MA, Lingford JP, John A, Soler NM, Scott NE, Goddard-Borger ED (May 2020). “Trefoil factors share a lectin activity that defines their role in mucus”. Nature Communications. 11 (1): 2265. Bibcode:2020NatCo..11.2265J. doi:10.1038/s41467-020-16223-7. PMC 7221086. PMID 32404934.
- In gastric carcinoma TFF1 expression is frequently lost in gastric carcinoma, probably through mechanism of DNA methylation, and it is therefore considered as a tumor suppressor gene.
- Feng G, Zhang Y, Yuan H, Bai R, Zheng J, Zhang J, Song M (Jan 2014). “DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma”. Mol Med Rep. 9 (1): 109–117. doi:10.3892/mmr.2013.1772. PMID 24190027.
- Further reading
- Langer G, Jagla W, Behrens-Baumann W, Walter S, Hoffmann W (2003). “Ocular TFF-peptides: new mucus-associated secretory products of conjunctival goblet cells”. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 506 (Pt A): 313–6. doi:10.1007/978-1-4615-0717-8_44. ISBN 978-1-4613-5208-2. PMID 12613926.
- Piggott NH, Henry JA, May FE, Westley BR (1991). “Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry”. J. Pathol. 163 (2): 95–104. doi:10.1002/path.1711630204. PMID 1707960. S2CID 2120939.
- Mori K, Fujii R, Kida N, Takahashi H, Ohkubo S, Fujino M, Ohta M, Hayashi K (1990). “Complete primary structure of the human estrogen-responsive gene (pS2) product”. J. Biochem. 107 (1): 73–6. doi:10.1093/oxfordjournals.jbchem.a123014. PMID 2185238.
- Tomasetto C, Rio MC, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R (1990). “hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma”. EMBO J. 9 (2): 407–14. doi:10.1002/j.1460-2075.1990.tb08125.x. PMC 551681. PMID 2303034.
- Takahashi H, Kida N, Fujii R, Tanaka K, Ohta M, Mori K, Hayashi K (1990). “Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma”. FEBS Lett. 261 (2): 283–6. doi:10.1016/0014-5793(90)80572-Z. PMID 2311759. S2CID 37115994.
- Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A, Chambon P (1988). “Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa”. Science. 241 (4866): 705–8. Bibcode:1988Sci…241..705R. doi:10.1126/science.3041593. PMID 3041593.
- Rio MC, Lepage P, Diemunsch P, Roitsch C, Chambon P (1989). “[Primary structure of human protein pS2]”. Comptes Rendus de l’Académie des Sciences, Série III. 307 (19): 825–31. PMID 3146413.
- Mori K, Fujii R, Kida N, Ohta M, Hayashi K (1988). “Identification of a polypeptide secreted by human breast cancer cells (MCF-7) as the human estrogen-responsive gene (pS2) product”. Biochem. Biophys. Res. Commun. 155 (1): 366–72. doi:10.1016/S0006-291X(88)81094-5. PMID 3261981.
- Jeltsch JM, Roberts M, Schatz C, Garnier JM, Brown AM, Chambon P (1987). “Structure of the human oestrogen-responsive gene pS2”. Nucleic Acids Res. 15 (4): 1401–14. doi:10.1093/nar/15.4.1401. PMC 340557. PMID 3822834.
- Prud’homme JF, Fridlansky F, Le Cunff M, Atger M, Mercier-Bodart C, Pichon MF, Milgrom E (1985). “Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells”. DNA. 4 (1): 11–21. doi:10.1089/dna.1985.4.11. PMID 3838275.
- Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P (1984). “Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7”. Nucleic Acids Res. 12 (6): 2861–78. doi:10.1093/nar/12.6.2861. PMC 318711. PMID 6324130.
- Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA (1993). “Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach”. Gastroenterology. 105 (4): 1110–6. doi:10.1016/0016-5085(93)90956-d. PMID 8405856.
- Polshakov VI, Frenkiel TA, Westley B, Chadwick M, May F, Carr MD, Feeney J (1996). “NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide. Similarities to porcine spasmolytic peptide and evidence for a monomeric structure”. Eur. J. Biochem. 233 (3): 847–55. doi:10.1111/j.1432-1033.1995.847_3.x. PMID 8521850.
- Seib T, Blin N, Hilgert K, Seifert M, Theisinger B, Engel M, Dooley S, Zang KD, Welter C (1997). “The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3”. Genomics. 40 (1): 200–2. doi:10.1006/geno.1996.4511. PMID 9070946.
- Polshakov VI, Williams MA, Gargaro AR, Frenkiel TA, Westley BR, Chadwick MP, May FE, Feeney J (1997). “High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein”. J. Mol. Biol. 267 (2): 418–32. doi:10.1006/jmbi.1997.0896. PMID 9096235.
- Chadwick MP, Westley BR, May FE (1997). “Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58”. Biochem. J. 327 (1): 117–23. doi:10.1042/bj3270117. PMC 1218770. PMID 9355742.
- Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM (1999). “Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase”. Cell. 98 (5): 675–86. doi:10.1016/S0092-8674(00)80054-9. PMID 10490106. S2CID 14697597.
- Newton JL, Allen A, Westley BR, May FE (2000). “The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach”. Gut. 46 (3): 312–20. doi:10.1136/gut.46.3.312. PMC 1727855. PMID 10673290.
- Trefoil factor 1 is a protein that in humans is encoded by the TFF1 gene (also called pS2 gene).
- TFF2,
- Trefoil factor 2 is a protein that in humans is encoded by the TFF2 gene.
- Tomasetto C, Rockel N, Mattei MG, Fujita R, Rio MC (Sep 1992). “The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q 22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2”. Genomics. 13 (4): 1328–30. doi:10.1016/0888-7543(92)90059-2. PMID 1505966.
- Gott P, Beck S, Machado JC, Carneiro F, Schmitt H, Blin N (May 1997). “Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression”. Eur J Hum Genet. 4 (6): 308–15. doi:10.1159/000472224. PMID 9043862. S2CID 25235589.
- “Entrez Gene: TFF2 trefoil factor 2 (spasmolytic protein 1)”.
- Members of the trefoil family are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides. They are stable secretory proteins expressed in gastrointestinal mucosa. Their functions are not defined, but they may protect the mucosa from insults, stabilize the mucus layer and affect healing of the epithelium. The encoded protein inhibits gastric acid secretion. This gene and two other related trefoil family member genes are found in a cluster on chromosome 21.
- Glycan binding All human trefoil factors are lectins that interact specifically with the disaccharide GlcNAc-α-1,4-Gal. This disaccharide is an unusual glycotope that is only known to exist on the large, heavily glycosylated, mucins in the mucosa. By cross-linking mucins through the bivalent binding of this glycotope, the trefoil factors are then able to reversibly modulate the thickness and viscosity of the mucus.
- Järvå MA, Lingford JP, John A, Soler NM, Scott NE, Goddard-Borger ED (May 2020). “Trefoil factors share a lectin activity that defines their role in mucus”. Nature Communications. 11 (1): 2265. Bibcode:2020NatCo..11.2265J. doi:10.1038/s41467-020-16223-7. PMC 7221086. PMID 32404934.
- Further reading
- Advenier C, Lagente V, Boichot E (1997). “The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough”. Eur. Respir. J. 10 (8): 1892–906. doi:10.1183/09031936.97.10081892. PMID 9272936.
- Langer G, Jagla W, Behrens-Baumann W, et al. (2003). “Ocular TFF-peptides: new mucus-associated secretory products of conjunctival goblet cells”. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 506 (Pt A): 313–6. doi:10.1007/978-1-4615-0717-8_44. ISBN 978-1-4613-5208-2. PMID 12613926.
- Tomasetto C, Rio MC, Gautier C, et al. (1990). “hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma”. EMBO J. 9 (2): 407–14. doi:10.1002/j.1460-2075.1990.tb08125.x. PMC 551681. PMID 2303034.
- Bhogal N, Donnelly D, Findlay JB (1994). “The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor”. J. Biol. Chem. 269 (44): 27269–74. doi:10.1016/S0021-9258(18)46979-7. PMID 7961636.
- Hanby AM, Poulsom R, Singh S, et al. (1993). “Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach”. Gastroenterology. 105 (4): 1110–6. doi:10.1016/0016-5085(93)90956-d. PMID 8405856.
- Itoh H, Tomita M, Uchino H, et al. (1996). “cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis”. Biochem. J. 318 (3): 939–44. doi:10.1042/bj3180939. PMC 1217708. PMID 8836141.
- May FE, Westley BR (1997). “Close physical linkage of the genes encoding the pNR-2/pS2 protein and human spasmolytic protein (hSP)”. Hum. Genet. 99 (3): 303–7. doi:10.1007/s004390050362. PMID 9050913. S2CID 22603186.
- Seib T, Blin N, Hilgert K, et al. (1997). “The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3”. Genomics. 40 (1): 200–2. doi:10.1006/geno.1996.4511. PMID 9070946.
- Kayademir T, Silva Edos S, Pusch C, et al. (1998). “A novel 25 bp tandem repeat within the human trefoil peptide gene TFF2 in 21q22.3: polymorphism and mammalian evolution”. Eur. J. Hum. Genet. 6 (2): 121–8. doi:10.1038/sj.ejhg.5200166. PMID 9781055.
- Brunelleschi S, Bordin G, Colangelo D, Viano I (1999). “Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis”. Neuropeptides. 32 (3): 215–23. doi:10.1016/S0143-4179(98)90040-3. PMID 10189055. S2CID 40222022.
- May FE, Semple JI, Newton JL, Westley BR (2000). “The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach”. Gut. 46 (4): 454–9. doi:10.1136/gut.46.4.454. PMC 1727891. PMID 10716671.
- Hattori M, Fujiyama A, Taylor TD, et al. (2000). “The DNA sequence of human chromosome 21”. Nature. 405 (6784): 311–9. Bibcode:2000Natur.405..311H. doi:10.1038/35012518. PMID 10830953.
- Berry A, Scott HS, Kudoh J, et al. (2001). “Refined localization of autosomal recessive nonsyndromic deafness DFNB10 locus using 34 novel microsatellite markers, genomic structure, and exclusion of six known genes in the region”. Genomics. 68 (1): 22–9. doi:10.1006/geno.2000.6253. PMID 10950923.
- Bulitta CJ, Fleming JV, Raychowdhury R, et al. (2002). “Autoinduction of the trefoil factor 2 (TFF2) promoter requires an upstream cis-acting element”. Biochem. Biophys. Res. Commun. 293 (1): 366–74. doi:10.1016/S0006-291X(02)00199-7. PMID 12054609.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS…9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Hu GY, Yu BP, Dong WG, et al. (2003). “Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa”. World J. Gastroenterol. 9 (5): 910–4. doi:10.3748/wjg.v9.i5.910. PMC 4611396. PMID 12717829.
- Trefoil factor 2 is a protein that in humans is encoded by the TFF2 gene.
- TFF3,
- Trefoil factor 3 is a protein that in humans is encoded by the TFF3 gene.
- Thim L, Woldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK (May 1995). “Characterization of human and rat intestinal trefoil factor produced in yeast”. Biochemistry. 34 (14): 4757–64. doi:10.1021/bi00014a033. PMID 7718582.
- Gott P, Beck S, Machado JC, Carneiro F, Schmitt H, Blin N (May 1997). “Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression”. Eur J Hum Genet. 4 (6): 308–15. doi:10.1159/000472224. PMID 9043862. S2CID 25235589.
- “Entrez Gene: TFF3 trefoil factor 3 (intestinal)”.
- Function Members of the trefoil family are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfide bonds. They are stable secretory proteins expressed in gastrointestinal mucosa. Their functions are diverse, including protection of the mucosa, thickening of the mucus, and increasing epithelial healing rates. This gene is a marker of columnar epithelium and is expressed in a variety of tissues including goblet cells of the intestines and colon. This gene and two other related trefoil family member genes are found in a cluster on chromosome 21.
- Glycan binding All three human trefoil factors are lectins that interact specifically with the disaccharide GlcNAc-α-1,4-Gal. This disaccharide is an unusual glycotope that is only known to exist on the large, heavily glycosylated, mucins in the mucosa. By cross-linking mucins through the bivalent binding of this glycotope, the trefoil factors are then able to reversibly modulate the thickness and viscosity of the mucus.
- Järvå MA, Lingford JP, John A, Soler NM, Scott NE, Goddard-Borger ED (May 2020). “Trefoil factors share a lectin activity that defines their role in mucus”. Nature Communications. 11 (1): 2265. Bibcode:2020NatCo..11.2265J. doi:10.1038/s41467-020-16223-7. PMC 7221086. PMID 32404934.
- In breast milk Trefoil factors (TFF) are secretory products of mucin producing cells. They play a key role in the maintenance of the surface integrity of oral mucosa and enhance healing of the gastrointestinal mucosa by a process called restitution. TFF comprises the gastric peptides (TFF1), spasmolytic peptide (TFF2), and the intestinal trefoil factor (TFF3, this protein). They have an important and necessary role in epithelial restitution within the gastrointestinal tract. Significant amounts of TFF are present in human milk. Evidence has been presented that TFF3 isolated from milk strongly correlates with downregulation of IL-6 and IL-8 in human intestinal epithelial cells. On the other hand, TFF3 activated the epithelial cells in culture to produce beta defensins 2 (hBD2) and beta defensins 4 (hBD4). These findings suggest that TFF can activate intestinal epithelial cells and could actively participate in the immune system of breastfed babies by inducing the production of peptides related to innate defence, such as defensins.]
- Barrera GJ, Sanchez G, Gonzalez JE (November 2012). “Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29”. Bosn J Basic Med Sci. 12 (4): 256–64. doi:10.17305/bjbms.2012.2448. PMC 4362502. PMID 23198942.
- Activation of PAR-2 receptors Two main mechanisms have been described for the activation of PAR-2: (A) by specific cleavage that unmask the receptor-activating peptide sequence present in the extracellular N-terminal domain of each PAR, leading to cell signaling via interaction of the exposed tethered ligand with the body of the receptor itself; and (B) by synthetic peptides, such as SLIGKV, that bind to the receptor, mimicking the actions of agonist proteases. During lactation, TFF3 secreted in human milk may activate intestinal epithelial cells through PAR-2 receptors, which in turn induces hBD2 and hBD4 expression and cytokine regulation.
- Barrera GJ, Tortolero GS (2016). “Trefoil factor 3 (TFF3) from human breast milk activates PAR-2 receptors, of the intestinal epithelial cells HT-29, regulating cytokines and defensins”. Bratislavske Lekarske Listy. 117 (6): 332–9. doi:10.4149/bll_2016_066. PMID 27546365.
- Clinical significance Using TFF3 as a marker of columnar epithelium, a process using an ingestible oesophageal sampling device (Cytosponge) coupled with immunocytochemistry for trefoil factor 3 to improve the accuracy and acceptability of the detection/screening of Barrett’s oesophagus has been developed. However the clinical utility of such a test may be limited by frequent staining of TFF3 in gastric cardia and subsequent risk of false positives.
- Kadri SR, Lao-Sirieix P, O’Donovan M, Debiram I, Das M, Blazeby JM, Emery J, Boussioutas A, Morris H, Walter FM, Pharoah P, Hardwick RH, Fitzgerald RC (2010). “Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study”. BMJ. 341: c4372. doi:10.1136/bmj.c4372. PMC 2938899. PMID 20833740.
- Peitz U, Kouznetsova I, Wex T, Gebert I, Vieth M, Roessner A, Hoffmann W, Malfertheiner P (2004). “TFF3 expression at the esophagogastric junction is increased in gastro-esophageal reflux disease (GERD)”. Peptides. 25 (5): 771–7. doi:10.1016/j.peptides.2004.01.018. PMID 15177871. S2CID 23122603.
- Having little (but not nothing) to do with that I came across something called Roemheld syndrome that I want to make a note of. Roemheld syndrome (RS), or gastrocardiac syndrome,[Pelner, Louis (1944). The Diet Therapy of Disease: A Handbook of Practical Nutrition. Personal diet service.
ROEMHELD, L.; Treatment of Gastrocardiac Syndrome
][Hempen, Carl-Hermann; Fischer (MD.), Toni (2009-01-01). A Materia Medica for Chinese Medicine: Plants, Minerals, and Animal Products. Elsevier Health Sciences. ISBN 9780443100949.][Saeed, Mohammad; Bhandohal, Janpreet Singh; Visco, Ferdinand; Pekler, Gerald; Mushiyev, Savi (2018-05-09). “Gastrocardiac syndrome: A forgotten entity”. The American Journal of Emergency Medicine. 36 (8): 1525.e5–1525.e7. doi:10.1016/j.ajem.2018.05.002. ISSN 0735-6757. PMID 29764738. S2CID 21725954.][“Current Medical Literature volume 97 number 12” (PDF).p882 This complex of symptoms, for which the term “gastrocardiac syndrome” (gastric cardiopathy
][Hofmann, Robin; Bäck, Magnus (2021). “Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome”. Frontiers in Cardiovascular Medicine. 8: 764478. doi:10.3389/fcvm.2021.764478. ISSN 2297-055X. PMC 8635856. PMID 34869678.] or gastric cardiac syndrome[“Clinical experience of treating 82 cases of gastric cardiac syndrome with traditional Chinese medicine”.] or Roemheld–Techlenburg–Ceconi syndrome or gastric-cardia,[Modestus, Jamey Franciscus (October 2011). Roemheld Syndrome. Strupress. ISBN 9786137960998.] was a medical syndrome first coined by Ludwig von Roemheld (1871–1938) describing a cluster of cardiovascular symptoms stimulated by gastrointestinal changes. Although it is currently considered an obsolete medical diagnosis, recent studies have described similar clinical presentations and highlighted potential underlying mechanisms.[Saeed, Mohammad; Bhandohal, Janpreet Singh; Visco, Ferdinand; Pekler, Gerald; Mushiyev, Savi (2018-05-09). “Gastrocardiac syndrome: A forgotten entity”. The American Journal of Emergency Medicine. 36 (8): 1525.e5–1525.e7. doi:10.1016/j.ajem.2018.05.002. ISSN 0735-6757. PMID 29764738. S2CID 21725954.][Linz, Dominik; Hohl, Mathias; Vollmar, J; Ukena, C; Mahfoud, F; Böhm, M (January 2017). “Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction”. EP Europace. 19 (1): 16–20. doi:10.1093/europace/euw092. PMID 27247004. S2CID 24306731.][Ehlers, A; Mayou, RA; Sprigings, DC; Birkhead, J (1999). “Psychological and perceptual factors associated with arrhythmias and benign palpitations”. Psychosomatic Medicine. 62 (5): 693–702. doi:10.1097/00006842-200009000-00014. PMID 11020100. S2CID 23760133.][Hofmann, Robin; Bäck, Magnus (2021). “Gastro-Cardiology: A Novel Perspective for the Gastrocardiac Syndrome”. Frontiers in Cardiovascular Medicine. 8: 764478. doi:10.3389/fcvm.2021.764478. ISSN 2297-055X. PMC 8635856. PMID 34869678.] - Further reading
- Lok, NS; Lau, CP (June 1996). “Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly”. International Journal of Cardiology. 54 (3): 231–6. doi:10.1016/0167-5273(96)02601-0. PMID 8818746.
- Sharma, Shekhar. “Roemheld Syndrome – Gastric Cardia”. roemheld-syndrome.com. Retrieved 28 March 2017.
- Roman, C; Bruley des Varannes, S; Muresan, L; Picos, A; Dumitrascu, DL (28 July 2014). “Atrial fibrillation in patients with gastroesophageal reflux disease: a comprehensive review”. World Journal of Gastroenterology. 20 (28): 9592–9. doi:10.3748/wjg.v20.i28.9592. PMC 4110594. PMID 25071357.
- Dittler, Edgar Leon; McGavack, Thomas H. (September 1938). “Pancreatic necrosis associated with auricular fibrillation and flutter”. American Heart Journal. 16 (3): 354–362. doi:10.1016/S0002-8703(38)90615-5.
- Having little (but not nothing) to do with that I came across something called Roemheld syndrome that I want to make a note of. Roemheld syndrome (RS), or gastrocardiac syndrome,[Pelner, Louis (1944). The Diet Therapy of Disease: A Handbook of Practical Nutrition. Personal diet service.
- Trefoil factor 3 is a protein that in humans is encoded by the TFF3 gene.
- ZP4
- Zona pellucida sperm-binding protein 4, ZP-4 or avilesine, named after its discoverer Manuel Avilés Sánchez is a protein that in humans is encoded by the ZP4 gene.
- Avilés M, Moros C, García-Vázquez FA, Gimeno L, Torrecillas A, Aliaga C, Bernardo-Pisa MV, Ballesta J, Izquierdo-Rico MJ (April 2015). “Four glycoproteins are expressed in the cat zona pellucida”. Theriogenology. 83 (7): 1162–73. doi:10.1016/j.theriogenology.2014.12.019. PMID 25623231.
- Harris JD, Hibler DW, Fontenot GK, Hsu KT, Yurewicz EC, Sacco AG (Mar 1995). “Cloning and characterization of zona pellucida genes and cDNAs from a variety of mammalian species: the ZPA, ZPB and ZPC gene families”. DNA Sequence. 4 (6): 361–93. doi:10.3109/10425179409010186. PMID 7841460.
- “Entrez Gene: ZP4 zona pellucida glycoprotein 4”.
- Function The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. The nascent protein contains a N-terminal signal peptide sequence, a conserved zona pellucida-like domain, a consensus furin cleavage site, and a C-terminal transmembrane domain. It is hypothesized that furin cleavage results in release of the mature protein from the plasma membrane for subsequent incorporation into the zona pellucida matrix. However, the requirement for furin cleavage in this process remains controversial based on mouse studies.
- Previously, this gene has been referred to as ZP1 or ZPB and thought to have similar functions as mouse Zp1. However, a human gene with higher similarity and chromosomal synteny to mouse Zp1 has been assigned the symbol ZP1 and this gene has been assigned the symbol ZP4.
- “Entrez Gene: ZP4 zona pellucida glycoprotein 4”.
- Conner SJ, Lefièvre L, Hughes DC, Barratt CL (May 2005). “Cracking the egg: increased complexity in the zona pellucida”. Human Reproduction. 20 (5): 1148–52. doi:10.1093/humrep/deh835. PMID 15760956.
- Further reading
- Rankin T, Dean J (May 2000). “The zona pellucida: using molecular genetics to study the mammalian egg coat”. Reviews of Reproduction. 5 (2): 114–21. doi:10.1530/ror.0.0050114. PMID 10864856.
- Eberspaecher U, Becker A, Bringmann P, van der Merwe L, Donner P (Feb 2001). “Immunohistochemical localization of zona pellucida proteins ZPA, ZPB and ZPC in human, cynomolgus monkey and mouse ovaries”. Cell and Tissue Research. 303 (2): 277–87. doi:10.1007/s004410000287. PMID 11291774. S2CID 20736190.
- Kiefer SM, Saling P (Feb 2002). “Proteolytic processing of human zona pellucida proteins”. Biology of Reproduction. 66 (2): 407–14. doi:10.1095/biolreprod66.2.407. PMID 11804956.
- Qi H, Williams Z, Wassarman PM (Feb 2002). “Secretion and assembly of zona pellucida glycoproteins by growing mouse oocytes microinjected with epitope-tagged cDNAs for mZP2 and mZP3”. Molecular Biology of the Cell. 13 (2): 530–41. doi:10.1091/mbc.01-09-0440. PMC 65647. PMID 11854410.
- Zhao M, Gold L, Ginsberg AM, Liang LF, Dean J (May 2002). “Conserved furin cleavage site not essential for secretion and integration of ZP3 into the extracellular egg coat of transgenic mice”. Molecular and Cellular Biology. 22 (9): 3111–20. doi:10.1128/MCB.22.9.3111-3120.2002. PMC 133755. PMID 11940668.
- Lefièvre L, Conner SJ, Salpekar A, Olufowobi O, Ashton P, Pavlovic B, Lenton W, Afnan M, Brewis IA, Monk M, Hughes DC, Barratt CL (Jul 2004). “Four zona pellucida glycoproteins are expressed in the human”. Human Reproduction. 19 (7): 1580–6. doi:10.1093/humrep/deh301. PMID 15142998.
- Chakravarty S, Suraj K, Gupta SK (May 2005). “Baculovirus-expressed recombinant human zona pellucida glycoprotein-B induces acrosomal exocytosis in capacitated spermatozoa in addition to zona pellucida glycoprotein-C”. Molecular Human Reproduction. 11 (5): 365–72. doi:10.1093/molehr/gah165. PMID 15805145.
- Furlong LI, Harris JD, Vazquez-Levin MH (Jun 2005). “Binding of recombinant human proacrosin/acrosin to zona pellucida (ZP) glycoproteins. I. Studies with recombinant human ZPA, ZPB, and ZPC”. Fertility and Sterility. 83 (6): 1780–90. doi:10.1016/j.fertnstert.2004.12.042. PMID 15950651.
- Caballero-Campo P, Chirinos M, Fan XJ, González-González ME, Galicia-Chavarría M, Larrea F, Gerton GL (Apr 2006). “Biological effects of recombinant human zona pellucida proteins on sperm function”. Biology of Reproduction. 74 (4): 760–8. doi:10.1095/biolreprod.105.047522. PMID 16407501.
- Zona pellucida sperm-binding protein 4, ZP-4 or avilesine, named after its discoverer Manuel Avilés Sánchez is a protein that in humans is encoded by the ZP4 gene.
History
There was a web server pKNOT available to detect knots in proteins as well as to provide information on knotted proteins in the Protein Data Bank.
- Lai YL, Yen SC, Yu SH, Hwang JK (2007). pKNOT: the protein KNOT web server. Nucleic Acids Research 35:W420-424
References
- Zarembinski TI, Kim Y, Peterson K, Christendat D, Dharamsi A, Arrowsmith CH, Edwards AM, Joachimiak A. (2003). Deep trefoil knot implicated in RNA binding found in an archaebacterial protein. Proteins 50(2):177-83
- Nureki O, Shirouzu M, Hashimoto K, Ishitani R, Terada T, Tamakoshi M, Oshima T, Chijimatsu M, Takio K, Vassylyev DG, Shibata T, Inoue Y, Kuramitsu S, Yokoyama S. (2002). An enzyme with a deep trefoil knot for the active-site architecture. Acta Crystallogr D 58(Pt 7):1129-37
- Nureki O, Watanabe K, Fukai S, Ishii R, Endo Y, Hori H, Yokoyama S. (2004). Deep knot structure for construction of active site and cofactor binding site of tRNA modification enzyme. Structure 12(4):593-602
- Leulliot N, Bohnsack MT, Graille M, Tollervey D, Van Tilbeurgh H.(2008). The yeast ribosome synthesis factor Emg1 is a novel member of the superfamily of alpha/beta knot fold methyltransferases. Nucleic Acids Res 36(2):629-39
- Mallam AL, Jackson SE. (2006). Probing nature’s knots: the folding pathway of a knotted homodimeric protein. J Mol Biol 359(5):1420-36
- Khatib F, Weirauch MT, Rohl CA. (2006). Rapid knot detection and application to protein structure prediction. Bioinformatics 22(14):e252-9
- (Jerome Gracy and Laurent Chiche (2010). Optimizing structural modeling for a specific protein scaffold: knottins or inhibitor cystine knots. BMC Bioinformatics. 11:535)
- Gajhede M, Petersen TN, Henriksen A, et al. (December 1993). “Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides”. Structure. 1 (4): 253–62. doi:10.1016/0969-2126(93)90014-8. PMID 8081739.
- Otto B, Wright N (1994). “Trefoil peptides. Coming up clover”. Curr. Biol. 4 (9): 835–838. doi:10.1016/S0960-9822(00)00186-X. PMID 7820556. S2CID 11245174.
- Thim L, Wright NA, Hoffmann W, Otto WR, Rio MC (1997). “Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer”. FEBS Lett. 408 (2): 121–123. doi:10.1016/S0014-5793(97)00424-9. PMID 9187350. S2CID 26946754.
- Bork P (1993). “A trefoil domain in the major rabbit zona pellucida protein”. Protein Sci. 2 (4): 669–670. doi:10.1002/pro.5560020417. PMC 2142363. PMID 8518738.
- Hoffmann W, Hauser F (1993). “The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia?”. Trends Biochem. Sci. 18 (7): 239–243. doi:10.1016/0968-0004(93)90170-R. PMID 8267796.
- Lai YL, Yen SC, Yu SH, Hwang JK (2007). pKNOT: the protein KNOT web server. Nucleic Acids Research 35:W420-424
External links
Bibliography
- Tkaczuk KL, Dunin-Horkawicz S, Purta E, Bujnicki JM. (2007). Structural and evolutionary bioinformatics of the SPOUT superfamily of methyltransferases. BMC Bioinformatics. 8:73
This article incorporates text from the public domain Pfam and InterPro: IPR000519